Identification of the m6Am methyltransferase PCIF1 reveals the location and functions of m6Am in the transcriptome K Boulias, D Toczydłowska-Socha, BR Hawley, N Liberman, K Takashima, ... Molecular cell 75 (3), 631-643. e8, 2019 | 262 | 2019 |
STING in tumor and host cells cooperatively work for NK cell-mediated tumor growth retardation K Takashima, Y Takeda, H Oshiumi, H Shime, M Okabe, M Ikawa, ... Biochemical and Biophysical Research Communications 478 (4), 1764-1771, 2016 | 93 | 2016 |
RIOK3-mediated phosphorylation of MDA5 interferes with its assembly and attenuates the innate immune response K Takashima, H Oshiumi, H Takaki, M Matsumoto, T Seya Cell reports 11 (2), 192-200, 2015 | 86 | 2015 |
Adjuvant for vaccine immunotherapy of cancer–focusing on Toll‐like receptor 2 and 3 agonists for safely enhancing antitumor immunity T Seya, H Shime, Y Takeda, M Tatematsu, K Takashima, M Matsumoto Cancer science 106 (12), 1659-1668, 2015 | 64 | 2015 |
Circulating extracellular vesicle microRNAs associated with adverse reactions, proinflammatory cytokine, and antibody production after COVID-19 vaccination Y Miyashita, T Yoshida, Y Takagi, H Tsukamoto, K Takashima, T Kouwaki, ... npj Vaccines 7 (1), 16, 2022 | 45 | 2022 |
Adjuvant immunotherapy for cancer: both dendritic cell-priming and check-point inhibitor blockade are required for immunotherapy T Seya, Y Takeda, K Takashima, S Yoshida, M Azuma, M Matsumoto Proceedings of the Japan Academy, Series B 94 (3), 153-160, 2018 | 35 | 2018 |
DNAJB1/HSP40 Suppresses Melanoma Differentiation-Associated Gene 5-Mitochondrial Antiviral Signaling Protein Function in Conjunction with HSP70 K Takashima, H Oshiumi, M Matsumoto, T Seya Journal of innate immunity 10 (1), 44-55, 2018 | 30 | 2018 |
Toll‐like receptor 3 signal augments radiation‐induced tumor growth retardation in a murine model S Yoshida, H Shime, Y Takeda, JM Nam, K Takashima, M Matsumoto, ... Cancer science 109 (4), 956-965, 2018 | 28 | 2018 |
Vaccine immunotherapy with ARNAX induces tumor‐specific memory T cells and durable anti‐tumor immunity in mouse models Y Takeda, S Yoshida, K Takashima, N Ishii‐Mugikura, H Shime, T Seya, ... Cancer science 109 (7), 2119-2129, 2018 | 25 | 2018 |
cGAMP Promotes Germinal Center Formation and Production of IgA in Nasal-Associated Lymphoid Tissue H Takaki, K Takashima, H Oshiumi, A Ainai, T Suzuki, H Hasegawa, ... Medical Sciences 5 (4), 35, 2017 | 21 | 2017 |
Role of epigenetics in unicellular to multicellular transition in Dictyostelium SY Wang, EA Pollina, IH Wang, LK Pino, HL Bushnell, K Takashima, ... Genome biology 22 (1), 134, 2021 | 17 | 2021 |
TICAM-1 is dispensable in STING-mediated innate immune responses in myeloid immune cells K Takashima, H Oshiumi, M Matsumoto, T Seya Biochemical and biophysical research communications 499 (4), 985-991, 2018 | 11 | 2018 |
The TLR3/TICAM-1 signal constitutively controls spontaneous polyposis through suppression of c-Myc in Apc Min/+ mice J Ono, H Shime, H Takaki, K Takashima, K Funami, S Yoshida, Y Takeda, ... Journal of biomedical science 24, 1-9, 2017 | 4 | 2017 |
RIOK3 keeps MDA5 inactive K Takashima, H Oshiumi, T Seya Oncotarget 6 (31), 30423, 2015 | 4 | 2015 |
HPV vaccines induce trained immunity and modulate pro‐inflammatory cytokine expression in response to secondary Toll‐like receptor stimulations M Yamaguchi, YS Mtali, H Sonokawa, K Takashima, Y Fukushima, ... Microbiology and Immunology 68 (2), 65-74, 2024 | 2 | 2024 |
Cholesterol restriction primes antiviral innate immunity via SREBP1-driven noncanonical type I IFNs T Nishimura, T Kouwaki, K Takashima, A Ochi, YS Mtali, H Oshiumi EMBO reports 26 (2), 560-592, 2025 | 1 | 2025 |
NOP16 is a histone mimetic that regulates Histone H3K27 methylation and gene repression K Takashima, DJ Lee, MF Trovero, MH Rothi, M Mistry, Y Zhang, Z Li, ... bioRxiv, 2023.06. 13.544862, 2023 | | 2023 |
The protein kinase RIOK3 suppressed MDA5-dependent innate immune response K Takashima, H Oshiumi, H Takaki, M Matsurnoto, T Seya CYTOKINE 100, 37-37, 2017 | | 2017 |